Publication | Closed Access

CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1

InflammationAnti-inflammatoryMedicineImmunologyPathologyCell DeathChronic InflammationDoxorubicin-induced Cardiac DysfunctionCardiovascular ToxicityPharmacologyInflammatory DiseaseCell Signaling